Category

Regulatory Affairs

Regulatory affairs updates from MPCA's regulatory watch: guidance, procedures and compliance changes for medicines across the Benelux.

Regulatory Affairs
16 Oct 2026

CPHI Milan 2026: what we took away from three days in Milan

Our team spent three days at CPHI Milan. Here is what stood out and what it means for...

Read more
CBG modernises its registration systems from May 2026 Regulatory Affairs
11 Aug 2026

CBG modernises its registration systems: what MAH holders need to know

The CBG-MEB is modernising its registration systems: new case numbers, digital signatures and submissions only via Common Repository...

Read more
Upcoming European healthcare legislation: five initiatives reshaping life sciences Regulatory Affairs
11 Aug 2026

Upcoming European healthcare legislation: are you ready?

Biotech Act, MDR/IVDR revision, Critical Medicines Act, new EU Pharmaceutical Legislation and stricter advertising rules: five initiatives to...

Read more
MPCA International - Article 10 and the Responsible Person for Information and Publicity (RIP) in Belgium Regulatory Affairs
11 Jun 2026

Article 10 and the RIP role: takeaways from the FAMHP info session

Several MPCA colleagues attended the FAMHP’s info session on Article 10. Here is what the updated guidance means...

Read more

Need help navigating the Benelux regulatory landscape?

Our team of specialists is ready to support you — from regulatory strategy and pharmacovigilance to market access and quality assurance.

Request a free consultation Our services

Your reference partner for Regulatory Affairs, Pharmacovigilance and Quality Affairs in the Benelux. Active since 1998 from Ghent, Belgium.

Accreditations

QP GMP RP GDP RIP EU QPPV/LCP
Services
Applications
Company
Contact

© 2026 M.P.C.A. International BV  ·  Privacy policy  |  Cookie policy

QP GMP RP GDP RIP EU QPPV/LCP